As GALVmed R&D progresses and undertakes increasing technology assessments and early-stage development projects, there is a need to ensure the programmes transfer appropriate processes and methods from research partners to the animal health industry.
GALVmed R&D also has a strong link into the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), hosted at the Pirbright Institute (Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) | The Pirbright Institute), and will work together with CVIM to identify suitable interventions for key diseases impacting low- and middle-income countries.